Pam Zeitlin
Professor and Chair of Pediatrics · University of Colorado School of Medicine
Credentials: · · · ·
History
- Present
Pediatrics Department · University of Colorado School of Medicine
- 1983–1984
1979–1983
Research
Proceedings of the National Academy of Sciences of the United States of America · 1993 · 442 citations
Immunocytochemical localization of the cystic fibrosis gene product CFTR
Proceedings of the National Academy of Sciences of the United States of America · 1991 · 407 citations
Nature · 1992 · 401 citations
16 papers
15 papers
- GC
11 papers
- TF
10 papers
- BR
8 papers
8 papers
- CB
8 papers
- RG
8 papers
Grants
- 2022–2024
Mechanism of Prostone Activation During CFTR Modulation
National Heart, Lung, and Blood Institute · R56
Contact PI · $426.8K · National Jewish Health
- 2016–2021
Ph 1-2 Study of Glycerolphenylbutyrate for Cystic Fibrosis IND 125,124 (12/5/15)
Food and Drug Administration · R01
Contact PI · $355.5K · National Jewish Health
- 2015–2019
Defining the Pulmonary Attributes of Pre-Symptomatic Lung Disease in Cystic Fibrosis
National Heart, Lung, and Blood Institute · R01
PI · $950.8K · Johns Hopkins University
- 2003–2018
Multidisciplinary Training Program in Pediatric Pulmonary
National Heart, Lung, and Blood Institute · T32
Contact PI · $3.2M · Johns Hopkins University
Clinical trials
- 2018–2022
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
Principal investigator · Terminated · Phase 1, Phase 2
National Jewish Health
- 2016–2017
Principal investigator · Completed · Phase 3
AstraZeneca
- 2010–2016
Phase II Study of Digitoxin to Treat Cystic Fibrosis
Principal investigator · Completed · Phase 2
National Jewish Health
- 2000–2002
Principal investigator · Completed · Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)